With the appearance of new treatment molecules modifying the disease evolution (disease modifying drugs - DMD), one of the major challenges in treating multiple sclerosis is now to overcome classical clinical criteria, such as the expanded disability status scale (EDSS), to go towards more sensitive and specific criteria. ![]() It is characterized by widespread inflammation, focal demyelination, and a variable degree of axonal loss. Multiple Sclerosis (MS) is a chronic inflammatory disease of the central nervous system affecting around 2.5 million persons worldwide, with a prevalence rate of 00 (higher rates in countries of the northern hemisphere) and a woman:man ratio of around 2.0 1. In addition, we demonstrate that computing a statistically robust consensus of the algorithms performs closer to human expertise on one score (segmentation) although still trailing on detection scores. Results of the challenge highlighted that automatic algorithms, including the recent machine learning methods (random forests, deep learning, …), are still trailing human expertise on both detection and delineation criteria. Each case was annotated manually by an unprecedented number of seven different experts. This computing infrastructure was used to evaluate thirteen methods of MS lesions segmentation, exploring a broad range of state-of-theart algorithms, against a high-quality database of 53 MS cases coming from four centers following a common definition of the acquisition protocol. This allowed for the automatic and independent evaluation of a large range of algorithms in a fair and completely automatic manner. ![]() This challenge was operated using a new open-science computing infrastructure. We present a study of multiple sclerosis segmentation algorithms conducted at the international MICCAI 2016 challenge.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |